These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6132134)

  • 1. Reversal of cancer.
    Lancet; 1983 Apr; 1(8328):799-800. PubMed ID: 6132134
    [No Abstract]   [Full Text] [Related]  

  • 2. Thioproline and reversal of cancer.
    Gosálvez M
    Lancet; 1983 May; 1(8333):1108. PubMed ID: 6133140
    [No Abstract]   [Full Text] [Related]  

  • 3. [Transrecters. A new group of inducers of reverse transformation with possible use in the treatment of human cancer].
    Gosálvez M; Blanco MF; de Paz E
    Rev Esp Oncol; 1982; 29(4):821-6. PubMed ID: 6927374
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary clinical results with norgamem (thioproline) and revercan (2-amino-2-thiazoline): the first inducers of reverse transformation.
    Brugarolas A; Gosálvez M
    Recent Results Cancer Res; 1982; 80():346-50. PubMed ID: 7036296
    [No Abstract]   [Full Text] [Related]  

  • 5. Thiazolidine-4-carboxylic acid, a selective drug against human cancers.
    Hahn FE
    Naturwissenschaften; 1980 Jun; 67(6):307. PubMed ID: 6995861
    [No Abstract]   [Full Text] [Related]  

  • 6. New targets for cancer chemotherapy.
    Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
    Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of differentiation therapy].
    Hozumi M
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1006-8. PubMed ID: 8512331
    [No Abstract]   [Full Text] [Related]  

  • 8. Differentiation therapy.
    Spira AI; Carducci MA
    Curr Opin Pharmacol; 2003 Aug; 3(4):338-43. PubMed ID: 12901941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reversion of cancer and mitochondrial filamentation].
    Gosálvez Gosálvez M
    An R Acad Nac Med (Madr); 2000; 117(4):825-34. PubMed ID: 11382156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials referral resource. Clinical trials of MGI-114.
    Murgo A; Cannon DJ; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Feb; 13(2):233, 237-8. PubMed ID: 10079472
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials referral resource. Current clinical trials of epothilone B analog (BMS-247550).
    Colevas AD; West PJ; Cheson BD
    Oncology (Williston Park); 2001 Sep; 15(9):1168-9, 1172-5. PubMed ID: 11589064
    [No Abstract]   [Full Text] [Related]  

  • 12. Lessons of the laetrile study.
    Young CW
    Clin Bull; 1981; 11(3):99-101. PubMed ID: 7039867
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation agents in cancer therapy.
    Ferrari AC; Waxman S
    Cancer Chemother Biol Response Modif; 1994; 15():337-66. PubMed ID: 7779589
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of thioproline in advanced epidermoid head and neck tumors.
    Boccardo F; Barbieri A; Canobbio L; Guarneri D; Merlano M; Rosso R
    Cancer Treat Rep; 1982 Mar; 66(3):585-6. PubMed ID: 7060048
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental and clinical effects of anticoagulants on cancer progression.
    Van Noorden CJ; van Sluis GL; Spek CA
    Thromb Res; 2010 Apr; 125 Suppl 2():S77-9. PubMed ID: 20434011
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of cyto-differentiating agents in oncology].
    Gadzhieva SSh; Polosukhina ER; Nikolaeva TG; Treshchalina EM; Baryshnikov AIu; Nebol'sin VE; Antonov VG
    Vopr Onkol; 2006; 52(3):267-74. PubMed ID: 17191698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Main problems of the method of clinical study of new antineoplastic agents].
    Astrakhan VI
    Vestn Akad Med Nauk SSSR; 1966; 21(4):85-92. PubMed ID: 4882836
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of thioproline on experimental arrhythmia].
    Zhao HP; Feng GH
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):30-2. PubMed ID: 6232816
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of cellular differentiation and cell fate for cancer therapy.
    Moutouh-de Parseval LA; Chan KW
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1268-73. PubMed ID: 15648947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNS-595, a naphthyridine cell cycle inhibitor and stimulator of apoptosis for the treatment of cancers.
    Mills DA; Fekrazad HM; Verschraegen CF
    Curr Opin Investig Drugs; 2008 Jun; 9(6):647-57. PubMed ID: 18516764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.